Language:
English
In:
PLoS ONE, 01 January 2017, Vol.12(7), p.e0181081
Description:
The efficacy of cisplatin-based chemotherapy in cancer is limited by the occurrence of innate and acquired drug resistance. In order to better understand the mechanisms underlying acquired cisplatin resistance, we have compared the adenocarcinoma-derived non-small cell lung cancer (NSCLC) cell...
Keywords:
Sciences (General)
E-ISSN:
1932-6203
DOI:
10.1371/journal.pone.0181081
URL:
View full text in DOAJ
Bookmarklink